Mattias Mandorfer Selected Research

Alcoholic Liver Diseases (Alcoholic Liver Disease)

7/2023	The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension.
8/2022	Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis.
1/2021	Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mattias Mandorfer Research Topics

Disease

68	Fibrosis (Cirrhosis) 03/2024 - 05/2013
58	Liver Diseases (Liver Disease) 03/2024 - 01/2015
47	Portal Hypertension 03/2024 - 05/2013
21	Hemorrhage 02/2024 - 12/2017
20	Ascites 02/2024 - 01/2014
17	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 01/2013
17	Infections 08/2023 - 01/2013
15	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2017
13	Inflammation (Inflammations) 01/2024 - 01/2018
13	End Stage Liver Disease 06/2023 - 01/2017
10	Hepatitis C 10/2022 - 03/2015
9	Disease Progression 06/2023 - 09/2019
8	Varicose Veins (Varicose Vein) 03/2024 - 01/2018
8	Acute-On-Chronic Liver Failure 01/2024 - 10/2017
8	Thrombosis (Thrombus) 12/2023 - 07/2018
7	Non-alcoholic Fatty Liver Disease 08/2023 - 01/2018
7	Chronic Hepatitis C 01/2021 - 01/2013
6	Hepatic Encephalopathy 02/2024 - 01/2018
5	COVID-19 12/2022 - 01/2021
4	Cholestasis 11/2023 - 02/2015
4	Coinfection 11/2021 - 11/2013
4	Fatty Liver 01/2020 - 01/2018
3	Chronic Hepatitis D 03/2024 - 01/2022
3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 02/2024 - 01/2022
3	Hepatitis 01/2024 - 01/2021
3	Sarcopenia 10/2023 - 08/2020
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 07/2023 - 01/2021
3	Chronic Hepatitis B 01/2023 - 01/2021
3	Anemia 12/2022 - 01/2014
3	HIV Infections (HIV Infection) 01/2016 - 05/2014
2	Thromboembolism 12/2023 - 10/2020
2	Bacterial Infections (Bacterial Infection) 12/2023 - 08/2023
2	Hyperbilirubinemia 11/2023 - 01/2023
2	Hyponatremia 10/2023 - 05/2021
2	Dyslipidemias (Dyslipidemia) 08/2023 - 09/2019
2	Brain Diseases (Brain Disorder) 02/2023 - 05/2021
2	Thrombophilia 01/2023 - 01/2022
2	Liver Failure 12/2022 - 01/2020
2	Liver Neoplasms (Liver Cancer) 04/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

19	4-(3-chlorophenylsulfanyl)piperidineIBA 03/2024 - 02/2015
16	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2014
13	InterferonsIBA 04/2022 - 11/2013
12	von Willebrand FactorIBA 03/2024 - 01/2020
11	Antiviral Agents (Antivirals)IBA 03/2024 - 11/2013
11	C-Reactive ProteinIBA 01/2024 - 01/2018
11	AlbuminsIBA 10/2023 - 01/2018
10	RNA (Ribonucleic Acid)IBA 08/2023 - 01/2013
9	BilirubinIBA 02/2024 - 12/2019
8	SodiumIBA 10/2023 - 09/2015
8	CreatinineIBA 10/2023 - 11/2015
7	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2015
6	Interleukin-6 (Interleukin 6)IBA 08/2023 - 05/2013
6	gadolinium ethoxybenzyl DTPA FDA Link 02/2023 - 01/2017
5	Thrombin FDA Link 02/2024 - 01/2022
5	AntigensIBA 01/2024 - 05/2020
5	Immunoglobulin M (IgM)IBA 05/2023 - 01/2021
5	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 11/2013
4	AmmoniaIBA 10/2023 - 02/2021
4	Immunoglobulin G (IgG)IBA 05/2023 - 05/2013
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2015
3	DiureticsIBA 02/2024 - 01/2018
3	Cytidine Triphosphate (CTP)IBA 10/2023 - 12/2019
3	Immunoglobulin A (IgA)IBA 05/2023 - 05/2013
3	ProcalcitoninIBA 05/2023 - 01/2021
3	Carvedilol (Coreg)FDA LinkGeneric 01/2023 - 01/2017
3	AnticoagulantsIBA 01/2023 - 07/2018
3	TransferasesIBA 01/2023 - 01/2019
3	Propranolol (Inderal)FDA LinkGeneric 01/2023 - 10/2018
3	nasIBA 10/2022 - 01/2021
3	Transaminases (Aminotransferases)IBA 01/2022 - 02/2015
3	ReninIBA 12/2021 - 01/2017
3	LipidsIBA 09/2019 - 01/2017
3	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2015
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2018 - 12/2017
3	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 06/2016 - 05/2014
2	Alkaline PhosphataseIBA 02/2024 - 12/2022
2	Epinephrine (Adrenaline)FDA LinkGeneric 12/2023 - 08/2022
2	Bile Acids and Salts (Bile Acids)IBA 11/2023 - 08/2023
2	EnzymesIBA 09/2023 - 01/2022
2	LipopolysaccharidesIBA 08/2023 - 08/2022
2	bulevirtideIBA 08/2023 - 01/2022
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023 - 12/2021
2	atezolizumabIBA 01/2023 - 01/2022
2	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2022
2	ThrombomodulinIBA 01/2023 - 01/2022
2	Choline (Choline Chloride)IBA 01/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2021
2	Complement C3 (C3 Complement)IBA 11/2022 - 01/2014
2	CollagenIBA 11/2022 - 08/2022

Therapy/Procedure

33	Therapeutics 02/2024 - 01/2013
16	Liver Transplantation 10/2023 - 10/2015
13	Transjugular Intrahepatic Portasystemic Shunt 10/2023 - 09/2017
8	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2023 - 12/2017
7	Ligation 11/2023 - 12/2017
4	Contraindications 10/2023 - 05/2014
4	Stents 08/2022 - 12/2017
3	Immunotherapy 10/2023 - 01/2022
3	Art Therapy 08/2023 - 01/2016
2	Duration of Therapy 08/2023 - 11/2013
2	Critical Care (Surgical Intensive Care) 02/2023 - 10/2021